Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic Cancer
Nguyen H. Tran, Vaibhav Sahai, Kent A. Griffith, Hari Nathan, Ravi Kaza, Kyle C. Cuneo, Jiaqi Shi, Edward Kim, Christopher J. Sonnenday, Clifford S. Cho, Theodore S. Lawrence, Mark M. Zalupski
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic Cancer'. Together they form a unique fingerprint.